O
131030
vs
ALC
ALC
Over the past 12 months, Optus Pharmaceutical Co Ltd has significantly outperformed ALC, delivering a return of +31% compared to the ALC's 21% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ALC
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
8 710
KRW
|
|||||
|
Alcon AG
SIX:ALC
|
64.44
CHF
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
131030, ALC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
O
|
Optus Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Alcon AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
131030, ALC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
|||||||||
|
|
Alcon AG
SIX:ALC
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
O
|
Optus Pharmaceutical Co Ltd | ||||
|
|
Alcon AG | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
131030, ALC
Performance Gap
131030, ALC
Performance By Year
131030, ALC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
|
| JP |
|
Hoya Corp
TSE:7741
|
|
| CH |
|
Alcon AG
SIX:ALC
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
